Clinical Trials Directory

Trials / Unknown

UnknownNCT05898347

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Nevoid Basal Cell Carcinomas in Young People With Gorlin Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The overall aim of the project is to gain knowledge about the expected course of nevoid basal cell carcinomas and the usefulness of dermatoscopy in young individuals with Gorlin syndrome. Clinical experience and some case-reports suggest that nevoid basal cell carcinomas have an indolent course with slow growth and that they can sometimes regress. However, no systematic research has previously been performed. Increased knowledge about nevoid basal cell carcinomas and the use of dermatoscopy could be of great clinical value in the follow-up and treatment of individuals with nevoid basal cell carcinoma syndrome.

Conditions

Interventions

TypeNameDescription
OTHERActive surveillanceSkin lesions clinically compatible with nevoid basal cell carcinomas are documented with measurements, clinical description, clinical photos and dermatoscopy photos every eight months for two years. Three representative skin lesions are selected at the first visit to be removed by skin biopsy at the end of the observation period (two years) for histopathological analyses. If a nevoid basal cell carcinoma shows a certain increases in size (according to pre-specified criteria of the study protocol), ulcerates, gets unevenly demarcated or give functional complaints during the observation period, the skin lesion will be excised.

Timeline

Start date
2023-06-01
Primary completion
2025-06-01
Completion
2025-12-31
First posted
2023-06-12
Last updated
2023-06-12

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05898347. Inclusion in this directory is not an endorsement.